2023 Q3 Form 10-K Financial Statement

#000149315223029992 Filed on August 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023
Revenue $796.1K $440.0K $1.257M
YoY Change 155.72% 558.09% 187.52%
Cost Of Revenue $563.8K $390.0K $930.2K
YoY Change
Gross Profit $232.3K $50.00K $326.7K
YoY Change
Gross Profit Margin 29.18% 11.36% 25.99%
Selling, General & Admin $2.460M $2.430M $8.030M
YoY Change 69.66% 66.17% 63.21%
% of Gross Profit 1058.83% 4860.0% 2458.15%
Research & Development $100.0K $130.0K $510.0K
YoY Change 25.0% -81.23% -86.77%
% of Gross Profit 43.04% 260.0% 156.12%
Depreciation & Amortization $247.6K $110.0K $814.5K
YoY Change
% of Gross Profit 106.57% 220.0% 249.33%
Operating Expenses $2.869M $2.700M $13.66M
YoY Change 87.53% 25.29% 55.68%
Operating Profit -$2.526M -$2.650M -$12.60M
YoY Change 107.36% 51.08%
Interest Expense $90.00K $30.00K $1.930M
YoY Change -33433.33% 66451.72%
% of Operating Profit
Other Income/Expense, Net $93.94K $1.931M
YoY Change 2087.73% 66475.1%
Pretax Income -$2.430M -$2.670M -$10.66M
YoY Change 100.83% 27.86% 27.91%
Income Tax
% Of Pretax Income
Net Earnings -$2.425M -$2.660M -$10.63M
YoY Change 100.71% 28.0% 28.0%
Net Earnings / Revenue -304.64% -604.55% -845.89%
Basic Earnings Per Share -$1.04 -$10.58
Diluted Earnings Per Share -$1.04 -$2.11 -$10.58
COMMON SHARES
Basic Shares Outstanding 2.330M shares 1.733M shares 1.005M shares
Diluted Shares Outstanding 2.330M shares 1.005M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $190.0K $1.540M $1.540M
YoY Change -96.69% -81.31% -81.31%
Cash & Equivalents $186.4K $1.537M
Short-Term Investments
Other Short-Term Assets $413.3K $552.8K $510.0K
YoY Change 177.52% -25.97% 212.63%
Inventory $965.1K $979.9K $980.0K
Prepaid Expenses $360.0K
Receivables $567.5K $293.9K $290.0K
Other Receivables $560.0K $20.13K $540.0K
Total Short-Term Assets $2.692M $3.863M $3.860M
YoY Change -67.2% -64.46% -64.48%
LONG-TERM ASSETS
Property, Plant & Equipment $664.9K $690.2K $1.240M
YoY Change 59.83% 76.33% 216.8%
Goodwill $3.803M
YoY Change
Intangibles $4.872M $5.255M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.009M $6.492M $6.490M
YoY Change 207.76% 337.42% 337.28%
TOTAL ASSETS
Total Short-Term Assets $2.692M $3.863M $3.860M
Total Long-Term Assets $6.009M $6.492M $6.490M
Total Assets $8.700M $10.35M $10.35M
YoY Change -14.36% -16.17% -16.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.630M $1.200M $1.200M
YoY Change 855.26% 67.62% 67.62%
Accrued Expenses $630.0K $777.1K $1.360M
YoY Change -34.38% -30.03% 22.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $340.0K $350.0K $350.0K
YoY Change
Total Short-Term Liabilities $6.846M $5.884M $5.880M
YoY Change 190.43% 26.18% 26.1%
LONG-TERM LIABILITIES
Long-Term Debt $310.0K $400.0K $400.0K
YoY Change
Other Long-Term Liabilities $310.0K $380.0K $380.0K
YoY Change -88.12% -66.77% -66.77%
Total Long-Term Liabilities $620.0K $780.0K $780.0K
YoY Change -76.25% -31.78% -31.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.846M $5.884M $5.880M
Total Long-Term Liabilities $620.0K $780.0K $780.0K
Total Liabilities $7.464M $6.668M $6.560M
YoY Change 50.37% 14.83% 14.54%
SHAREHOLDERS EQUITY
Retained Earnings -$44.23M -$41.81M
YoY Change 36.59% 34.1%
Common Stock $23.30K $23.30K
YoY Change -84.35% -84.35%
Preferred Stock
YoY Change
Treasury Stock (at cost) $14.00 $14.00
YoY Change
Treasury Stock Shares
Shareholders Equity $1.356M $3.799M $3.800M
YoY Change
Total Liabilities & Shareholders Equity $8.700M $10.35M $10.35M
YoY Change -14.36% -16.17% -16.21%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023
OPERATING ACTIVITIES
Net Income -$2.425M -$2.660M -$10.63M
YoY Change 100.71% 28.0% 28.0%
Depreciation, Depletion And Amortization $247.6K $110.0K $814.5K
YoY Change
Cash From Operating Activities -$1.312M -$590.0K -$7.377M
YoY Change -30.73% -65.76% 119.69%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions $363.5K
YoY Change
Other Investing Activities $0.00 -$180.0K -$690.0K
YoY Change -100.0% -74.4% -21.61%
Cash From Investing Activities -$180.0K -$694.1K
YoY Change -74.4% -21.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 50.00K $1.435M
YoY Change
NET CHANGE
Cash From Operating Activities -$1.312M -590.0K -$7.377M
Cash From Investing Activities -180.0K -$694.1K
Cash From Financing Activities 50.00K $1.435M
Net Change In Cash -$1.351M -720.0K -$6.701M
YoY Change -45.87% -70.32% 54.57%
FREE CASH FLOW
Cash From Operating Activities -$1.312M -$590.0K -$7.377M
Capital Expenditures
Free Cash Flow -$7.377M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001725430
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Auditor Firm
AuditorFirmId
2256
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
usd
CY2023Q2 us-gaap Grants Receivable Current
GrantsReceivableCurrent
usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
usd
CY2023Q2 us-gaap Grants Receivable Noncurrent
GrantsReceivableNoncurrent
usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2023Q2 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022 us-gaap Gross Profit
GrossProfit
usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2022 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
usd
CY2022 INBS Stock Issued During Period Value Series B Warrants Exercised To Purchase Common Shares
StockIssuedDuringPeriodValueSeriesBWarrantsExercisedToPurchaseCommonShares
usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023 INBS Stock Issued During Period Reverse Stock Split Rounding Adjustment
StockIssuedDuringPeriodReverseStockSplitRoundingAdjustment
usd
CY2023 INBS Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
usd
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023 INBS Noncash Research And Development Charge
NoncashResearchAndDevelopmentCharge
usd
CY2022 INBS Fair Value Gain On Revaluation Of Convertible Notes
FairValueGainOnRevaluationOfConvertibleNotes
usd
CY2022 INBS Fair Value Gain On Revaluation Of Holdback Series Preferred Stock
FairValueGainOnRevaluationOfHoldbackSeriesPreferredStock
usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2023 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
usd
CY2022 INBS Cash Acquired From Business Acquisition
CashAcquiredFromBusinessAcquisition
usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
CY2022 INBS Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
usd
CY2022 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2022 INBS Payment Of Equity Issuance Costs Relating To Acquisition
PaymentOfEquityIssuanceCostsRelatingToAcquisition
usd
CY2022 INBS Payment Of Tax Withholding For Employee Stock Awards
PaymentOfTaxWithholdingForEmployeeStockAwards
usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022 INBS Shares Issued For Business Acquisition
SharesIssuedForBusinessAcquisition
usd
CY2022 INBS Note Receivable Settled For Business Acquisition
NoteReceivableSettledForBusinessAcquisition
usd
CY2022 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
usd
CY2022 INBS Recording Of Rightofuse Asset And Lease Liability
RecordingOfRightofuseAssetAndLeaseLiability
usd
CY2022 INBS Conversion Of Convertible Notes Payable Into Preferred Stock
ConversionOfConvertibleNotesPayableIntoPreferredStock
usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
usd
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
usd
CY2022Q2 INBS Less Provision For Inventory Obsolescence
LessProvisionForInventoryObsolescence
usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
usd
CY2023Q2 INBS Intelligent Fingerprinting Limited Note Receivable
IntelligentFingerprintingLimitedNoteReceivable
usd
CY2022Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
usd
CY2022Q2 INBS Deferred Consideration Current
DeferredConsiderationCurrent
usd
CY2022Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
usd
CY2022Q2 us-gaap Goodwill
Goodwill
usd
CY2023Q2 us-gaap Goodwill
Goodwill
usd
CY2023 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
usd
CY2022Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
usd
CY2022Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 INBS Income Tax Reconciliation Tax Benefit On Carry Forward Losses Of Acquired Business
IncomeTaxReconciliationTaxBenefitOnCarryForwardLossesOfAcquiredBusiness
usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39825
CY2023 dei Entity Registrant Name
EntityRegistrantName
Intelligent Bio Solutions Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1512711
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Intelligent Bio Solutions Inc.
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
142 West, 57th Street
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
11th Floor
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10019
CY2023 dei City Area Code
CityAreaCode
646
CY2023 dei Local Phone Number
LocalPhoneNumber
828-8258
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023 dei Trading Symbol
TradingSymbol
INBS
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
3665058 usd
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2330399 shares
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4200000 usd
CY2023 dei Auditor Firm
AuditorFirmId
1195
CY2023 dei Auditor Name
AuditorName
UHY LLP
CY2023 dei Auditor Location
AuditorLocation
Melville, New York
CY2022 dei Auditor Name
AuditorName
BDO Audit Pty Ltd
CY2022 dei Auditor Location
AuditorLocation
Sydney, Australia
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1537244 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8238301 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
293861 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
979907 usd
CY2022Q2 us-gaap Grants Receivable Current
GrantsReceivableCurrent
1529882 usd
CY2023Q2 INBS Research And Development Tax Incentive Receivable Current
ResearchAndDevelopmentTaxIncentiveReceivableCurrent
498758 usd
CY2022Q2 INBS Research And Development Tax Incentive Receivable Current
ResearchAndDevelopmentTaxIncentiveReceivableCurrent
353048 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
552791 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
746761 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
3862561 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
10867992 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
690175 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
391408 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
546475 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5255401 usd
CY2022Q2 us-gaap Grants Receivable Noncurrent
GrantsReceivableNoncurrent
1092773 usd
CY2023Q2 us-gaap Assets
Assets
10354612 usd
CY2022Q2 us-gaap Assets
Assets
12352173 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2610028 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1625089 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
223447 usd
CY2023Q2 us-gaap Deferred Income Current
DeferredIncomeCurrent
2338057 usd
CY2022Q2 us-gaap Deferred Income Current
DeferredIncomeCurrent
2836582 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
358942 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
201332 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
353211 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5883685 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4663003 usd
CY2023Q2 INBS Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
24902 usd
CY2022Q2 INBS Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
50626 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
356165 usd
CY2022Q2 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
1092773 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
402862 usd
CY2023Q2 us-gaap Liabilities
Liabilities
6667614 usd
CY2022Q2 us-gaap Liabilities
Liabilities
5806402 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2330399 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
744495 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
23304 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
7445 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1386 shares
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
14 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
46158763 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38581465 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41807573 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31175853 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-575496 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-788135 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3798984 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6624922 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
-111986 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
-79151 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3686998 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6545771 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10354612 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12352173 usd
CY2023 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 20
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1256872 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
930204 usd
CY2023 us-gaap Gross Profit
GrossProfit
326668 usd
CY2023 INBS Government Support Income
GovernmentSupportIncome
737628 usd
CY2022 INBS Government Support Income
GovernmentSupportIncome
437146 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8026703 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4920103 usd
CY2023 INBS Development And Regulatory Approval Expenses
DevelopmentAndRegulatoryApprovalExpenses
507424 usd
CY2022 INBS Development And Regulatory Approval Expenses
DevelopmentAndRegulatoryApprovalExpenses
3853919 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
966732 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4158670 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
13659529 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
8774022 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-12595233 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-8336876 usd
CY2023 us-gaap Interest Expense Other
InterestExpenseOther
223534 usd
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
7539 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-9829 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-3987 usd
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
2154365 usd
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
9676 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
14426 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1930678 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2900 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-10664555 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-8333976 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-32835 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-27925 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-10631720 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8306051 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
212639 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-126875 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
212639 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-126875 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10451916 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8460851 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-32835 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-27925 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10419081 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8432926 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1004593 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1004593 shares
CY2023 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 20
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15006622 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-126875 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-8333976 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6545771 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6545771 usd
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4724270 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
162460 usd
CY2023 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
260000 usd
CY2023 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
14407 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2093667 usd
CY2023 INBS Stock Issued During Period Value Conversion Of Convertible Notes Payable Into Series C Preferred Stock
StockIssuedDuringPeriodValueConversionOfConvertibleNotesPayableIntoSeriesCPreferredStock
367153 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
212639 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-10664555 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3686998 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3686998 usd
CY2023 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 20
CY2023 us-gaap Profit Loss
ProfitLoss
-10664555 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-8333976 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
814481 usd
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
152251 usd
CY2023 INBS Noncash Gain Loss On Foreign Currency Translation Net
NoncashGainLossOnForeignCurrencyTranslationNet
-9829 usd
CY2022 INBS Noncash Gain Loss On Foreign Currency Translation Net
NoncashGainLossOnForeignCurrencyTranslationNet
3987 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
189670 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4158670 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
260000 usd
CY2022 INBS Noncash Research And Development Charge
NoncashResearchAndDevelopmentCharge
2600000 usd
CY2023 INBS Non Cash Refund Of Rd Expenditure Claims
NonCashRefundOfRdExpenditureClaims
127944 usd
CY2022 INBS Non Cash Refund Of Rd Expenditure Claims
NonCashRefundOfRdExpenditureClaims
50958 usd
CY2023 INBS Fair Value Gain On Revaluation Of Convertible Notes
FairValueGainOnRevaluationOfConvertibleNotes
-1537565 usd
CY2023 INBS Fair Value Gain On Revaluation Of Holdback Series Preferred Stock
FairValueGainOnRevaluationOfHoldbackSeriesPreferredStock
-616800 usd
CY2023 INBS Noncash Other Operating Activities
NoncashOtherOperatingActivities
94332 usd
CY2022 INBS Noncash Other Operating Activities
NoncashOtherOperatingActivities
8179 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
293861 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
345390 usd
CY2023 INBS Increase Decrease In Grant Receivable And Deferred Grant Income
IncreaseDecreaseInGrantReceivableAndDeferredGrantIncome
-1031357 usd
CY2022 INBS Increase Decrease In Grant Receivable And Deferred Grant Income
IncreaseDecreaseInGrantReceivableAndDeferredGrantIncome
-1828891 usd
CY2023 INBS Increase Decrease In Research And Development Tax Incentive Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable
145710 usd
CY2022 INBS Increase Decrease In Research And Development Tax Incentive Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable
-672407 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
118335 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
333743 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
84502 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
255978 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-13323 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-107922 usd
CY2023 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-25724 usd
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
28856 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7377378 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3358034 usd
CY2022 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
500000 usd
CY2023 INBS Cash Acquired From Business Acquisition
CashAcquiredFromBusinessAcquisition
174481 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
363500 usd
CY2023 INBS Amount Invested On Capital Work In Progress
AmountInvestedOnCapitalWorkInProgress
505123 usd
CY2022 INBS Amount Invested On Capital Work In Progress
AmountInvestedOnCapitalWorkInProgress
380221 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-694142 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-880221 usd
CY2023 INBS Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
2554463 usd
CY2023 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
220578 usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
518914 usd
CY2023 INBS Payment Of Equity Issuance Costs Relating To Acquisition
PaymentOfEquityIssuanceCostsRelatingToAcquisition
806397 usd
CY2023 INBS Payment Of Tax Withholding For Employee Stock Awards
PaymentOfTaxWithholdingForEmployeeStockAwards
14407 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1435323 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-64860 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-97129 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6701057 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4335384 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8238301 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12573685 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1537244 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8238301 usd
CY2023 INBS Shares Issued For Business Acquisition
SharesIssuedForBusinessAcquisition
5530667 usd
CY2023 INBS Note Receivable Settled For Business Acquisition
NoteReceivableSettledForBusinessAcquisition
504938 usd
CY2023 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
208500 usd
CY2023 INBS Recording Of Rightofuse Asset And Lease Liability
RecordingOfRightofuseAssetAndLeaseLiability
702566 usd
CY2023 INBS Conversion Of Convertible Notes Payable Into Preferred Stock
ConversionOfConvertibleNotesPayableIntoPreferredStock
367153 usd
CY2023 INBS Conversion Of Preferred Shares Into Common Shares
ConversionOfPreferredSharesIntoCommonShares
36888 usd
CY2022 INBS Conversion Of Preferred Shares Into Common Shares
ConversionOfPreferredSharesIntoCommonShares
13000 usd
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-20
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-10631720 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8306051 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3686998 usd
CY2023Q2 INBS Working Capital Deficit
WorkingCapitalDeficit
2021124 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41807573 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1537244 usd
CY2021Q2 us-gaap Deferred Income
DeferredIncome
4700000 usd
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
646116 usd
CY2022Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
391408 usd
CY2021Q2 us-gaap Deferred Income
DeferredIncome
4700000 usd
CY2023 us-gaap Accounts Receivable Sale
AccountsReceivableSale
1400000 usd
CY2022 us-gaap Accounts Receivable Sale
AccountsReceivableSale
2100000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zFgXr0WbsAT" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zrgqADXbx8y7">Use of estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p>
CY2023 INBS Earnings Per Share Basic Decreased
EarningsPerShareBasicDecreased
0.07
CY2023 INBS Earnings Per Share Diluted Decreased
EarningsPerShareDilutedDecreased
10.58
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1256872 usd
CY2023 INBS Research And Development Tax Refund
ResearchAndDevelopmentTaxRefund
609684 usd
CY2022 INBS Research And Development Tax Refund
ResearchAndDevelopmentTaxRefund
385888 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
212639 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
126875 usd
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
1114687 usd
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
7816077 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1256872 usd
CY2023 INBS Government Support Income
GovernmentSupportIncome
737628 usd
CY2022 INBS Government Support Income
GovernmentSupportIncome
437146 usd
CY2023Q2 INBS Property Plant And Equipment Net And Operating Lease Right Of Use Asset
PropertyPlantAndEquipmentNetAndOperatingLeaseRightOfUseAsset
1236650 usd
CY2022Q2 INBS Property Plant And Equipment Net And Operating Lease Right Of Use Asset
PropertyPlantAndEquipmentNetAndOperatingLeaseRightOfUseAsset
391408 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zgR8piUpgQtl" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_ziRKCSWtGS4l">Concentration of credit risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company places its cash and cash equivalents, which may at times be in excess of the Australia Financial Claims Scheme or the United States’ Federal Deposit Insurance Corporation insurance limits, with high credit quality financial institutions and attempts to limit the amount of credit exposure with any one institution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2022Q4 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
363500 usd
CY2022Q4 INBS Note Receivable Settled For Business Acquisition
NoteReceivableSettledForBusinessAcquisition
504938 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
7224404 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
174481 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
774625 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
345038 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
52170 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
5463000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
3803293 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
10612607 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
1027302 usd
CY2023Q2 INBS Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayable
-677137 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt
1683764 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
3388203 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
7224404 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4158670 usd
CY2023 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1256872 usd
CY2023 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-10664555 usd
CY2022 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-8333976 usd
CY2023 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-10631720 usd
CY2022 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-8306051 usd
CY2023 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-10.58
CY2022 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-11.33
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
419889 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
757518 usd
CY2023Q2 INBS Less Provision For Inventory Obsolescence
LessProvisionForInventoryObsolescence
197500 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
979907 usd
CY2022Q2 INBS Intelligent Fingerprinting Limited Note Receivable
IntelligentFingerprintingLimitedNoteReceivable
500445 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
359953 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
116525 usd
CY2023Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
20418 usd
CY2022Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
57746 usd
CY2023Q2 us-gaap Deposit Assets
DepositAssets
118193 usd
CY2022Q2 us-gaap Deposit Assets
DepositAssets
46602 usd
CY2023Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
34100 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
20127 usd
CY2022Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
25443 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
552791 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
746761 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
723944 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
391408 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33769 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
690175 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
391408 usd
CY2023 us-gaap Depreciation
Depreciation
33769 usd
CY2022 us-gaap Depreciation
Depreciation
0 usd
CY2023Q2 INBS Percentage Of Reimbursement On Construction Cost
PercentageOfReimbursementOnConstructionCost
0.50 pure
CY2023Q2 INBS Investments In Construction In Progress
InvestmentsInConstructionInProgress
1292232 usd
CY2022Q2 INBS Investments In Construction In Progress
InvestmentsInConstructionInProgress
782816 usd
CY2023Q2 INBS Government Grant
GovernmentGrant
646116 usd
CY2022Q2 INBS Government Grant
GovernmentGrant
391408 usd
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
646116 usd
CY2022Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
391408 usd
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1196222 usd
CY2022Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
715902 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
777086 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
909187 usd
CY2023Q2 INBS Deferred Consideration Current
DeferredConsiderationCurrent
208500 usd
CY2023Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
428220 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2610028 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1625089 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4200000 usd
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
3803293 usd
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
355377 usd
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
-4158670 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5463000 usd
CY2023Q2 INBS Effect Of Foreign Currency On Goodwill
EffectOfForeignCurrencyOnGoodwill
643183 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
850782 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5255401 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
850782 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
884416 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
884416 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
814135 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
790708 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
790708 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
988384 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5152767 usd
CY2023Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0097 pure
CY2023 INBS Percentage Of Gross Revenue Received
PercentageOfGrossRevenueReceived
0.10 pure
CY2023 INBS Percentage Of Subsequent Sales To Distributor
PercentageOfSubsequentSalesToDistributor
0.50 pure
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
152251 usd
CY2023 INBS Interest On Operating Lease Liabilities
InterestOnOperatingLeaseLiabilities
68357 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
220608 usd
CY2023Q2 us-gaap Lessee Finance Lease Remaining Lease Term
LesseeFinanceLeaseRemainingLeaseTerm
P2Y3M18D
CY2023Q2 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.132 pure
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
295369 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
308749 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
83534 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
687652 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
108040 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
579612 usd
CY2023Q2 INBS Offering Expenses
OfferingExpenses
2550000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
25000 shares
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
260000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
260000 usd
CY2023 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
1386 shares
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
5347487 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
1682879 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
153199 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
59546 usd
CY2023Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
38034 usd
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
77539 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9530704 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6064025 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9530704 usd
CY2023Q2 us-gaap Purchase Obligation
PurchaseObligation
0 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
3914445 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
4321600 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6064025 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2310635 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1770915 usd
CY2023 INBS Income Tax Reconciliation Income Tax Expense Benefit At Different Tax Rate Of Subsidiary
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtDifferentTaxRateOfSubsidiary
-18715 usd
CY2022 INBS Income Tax Reconciliation Income Tax Expense Benefit At Different Tax Rate Of Subsidiary
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtDifferentTaxRateOfSubsidiary
-106634 usd
CY2023 INBS Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
680221 usd
CY2022 INBS Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
117039 usd
CY2023 INBS Income Tax Reconciliation Tax Benefit On Carry Forward Losses Of Acquired Business
IncomeTaxReconciliationTaxBenefitOnCarryForwardLossesOfAcquiredBusiness
-3289886 usd
CY2023 INBS Income Tax Reconciliation Cumulative Adjustment To Deferred Taxes
IncomeTaxReconciliationCumulativeAdjustmentToDeferredTaxes
1681562 usd
CY2022 INBS Income Tax Reconciliation Cumulative Adjustment To Deferred Taxes
IncomeTaxReconciliationCumulativeAdjustmentToDeferredTaxes
1643216 usd
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-209226 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3466679 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-117294 usd
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
44492527 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
27310563 usd

Files In Submission

Name View Source Status
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
0001493152-23-029992-index-headers.html Edgar Link pending
0001493152-23-029992-index.html Edgar Link pending
0001493152-23-029992.txt Edgar Link pending
0001493152-23-029992-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex23-1_001.jpg Edgar Link pending
ex23-2.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-13.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
form10-k_002.jpg Edgar Link pending
inbs-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
inbs-20230630_def.xml Edgar Link unprocessable
inbs-20230630_cal.xml Edgar Link unprocessable
inbs-20230630_lab.xml Edgar Link unprocessable
inbs-20230630_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending